Shanghai OPM Biosciences (688293.SH) major shareholder China Life Gainreduces its holding by 1%.
Aopumai (688293.SH) announcement, the company's shareholder holding more than 5% of the shares, China Life Chengda (Shanghai) Health Industry equity...
Shanghai OPM Biosciences (688293.SH) announced that the shareholder China Life Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership) (referred to as "China Life Chengda") reduced its holdings of the company's shares by a total of 1.1477 million shares, representing 1.00% of the total share capital of the company, through centralized auction trading from November 7, 2024 to November 15, 2024.
Related Articles
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
